{
  "image_filename": "table_p8_det_7_002.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p8_det_7_002.png",
  "image_type": "Table",
  "page_number": 8,
  "block_id": "det_7_002",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A clinical table comparing two vaccine groups (N=279,400 vs. N=395,852) on primary and secondary outcomes, including PCR-confirmed influenza (overall, type A, type B) and various hospitalization endpoints, with rate ratios, hazard ratios, vaccine effectiveness percentages, confidence intervals, and P values. The table presents vaccine efficacy and hospitalization outcomes but does not provide any information about antigenic matching to WHO- or FDA-selected flu strains, and therefore does not support the claim. Note: None",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A clinical table comparing two vaccine groups (N=279,400 vs. N=395,852) on primary and secondary outcomes, including PCR-confirmed influenza (overall, type A, type B) and various hospitalization endpoints, with rate ratios, hazard ratios, vaccine effectiveness percentages, confidence intervals, and P values.",
    "evidence_found": null,
    "reasoning": "The table presents vaccine efficacy and hospitalization outcomes but does not provide any information about antigenic matching to WHO- or FDA-selected flu strains, and therefore does not support the claim.",
    "confidence_notes": "None"
  }
}